In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, David Magalashvili, Shay Menascu, Yehuda Warszawer, Mark Dolev, Maria Didikin, Gil Harari, Polina Sonis, Rina Falb, Michael Gurevich
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab'. Together they form a unique fingerprint.